X0306 4 2020-02-24 0 0001398659 Genpact LTD G 0001408239 Tyagarajan N. V. C/O GENPACT LLC 1155 AVENUE OF THE AMERICAS, 4TH FLOOR NEW YORK NY 10036 1 1 0 0 President and CEO Common Shares 2020-02-24 4 M 0 51052 14.3235 A 693215 D Common Shares 2020-02-24 4 S 0 51052 43.1555 D 642163 D Common Shares 10000 I By Trust Employee Stock Option (Right to Buy) 14.3235 2020-02-24 4 M 0 51052 0 D 2020-03-11 Common Shares 51052 0 D The exercise price reflects an adjustment that was made to preserve the value of the reporting person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.99 to $43.30. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein. The?option?vested?25%?on February 1, 2011 and each anniversary thereof. The number of derivative securities beneficially owned reflects an adjustment that was made to preserve the value of the reporting person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012. /s/ Thomas D. Scholtes, as Attorney-in-fact for N.V. Tyagarajan 2020-02-26